MethylGene: Making multiple bets

MethylGene: Making multiple bets

MethylGene Inc. believes in mitigating risk by taking multiple approaches to developing drugs for a given target, while also developing them in as many indications as possible. MethylGene's primary objective, said President and CEO Donald Corcoran, is to "get a target and take multiple cuts at it" using the company's three therapeutic development platforms: antisense, hairpin oligonucleotides and rationally designed small molecules.

Corcoran said MethylGene got its start when he was vice president of international

Read the full 785 word article

How to gain access

Continue reading with a
two-week free trial.